A4349 mandates that nearly all New Jersey health insurance contracts, state employee and school employee health benefit plans, and Medicaid cover abortion with no cost-sharing and no prior authorization, and bars medical malpractice insurers from taking adverse action against providers based on their performance of legally protected reproductive health services.
OUR POSITIONA4349, introduced February 19, 2026, and referred to the Assembly Financial Institutions and Insurance Committee, operates across four distinct coverage tiers. Sections 3, 4, and 5 reach private carrier contracts, the State Health Benefits Commission, and the School Employees' Health Benefits Commission respectively, requiring each to cover abortion without any deductible, copayment, coinsurance, or other cost-sharing. Section 3 also expressly bars prior authorization for abortion services. A separate provision prohibits medical malpractice insurers from taking adverse action against a provider solely on the basis of that provider performing legally protected reproductive health services. The bill defines "abortion" broadly to include aspiration procedures, medication abortion, and follow-up care, and defines "pregnancy" as beginning at implantation.
The bill's conscience accommodation is narrow and structurally limited. Only organizations qualifying as "religious employers" under 26 U.S.C. section 6033(a)(3)(A)(i) or (iii), a federal tax-code category confined to churches and certain church-controlled nonprofits, may request an exclusion from carriers. Carriers themselves receive no exemption. Faith-based hospitals, religiously affiliated universities, and other mission-driven organizations that do not meet the IRC section 6033 definition are left without any opt-out from sponsoring or purchasing compliant contracts. The bill does preserve a carve-out for care necessary to preserve the life or health of a covered person even within a religious employer exclusion, but that carve-out does not expand the class of employers eligible to seek one.
From a principled, faith-informed perspective, the bill's no-cost-sharing mandate is not a neutral access measure. Cost-sharing has historically served as one of the few remaining structural signals within insurance design that a procedure carries moral weight warranting individual deliberation. Eliminating it entirely for abortion, while retaining it for virtually all other services, encodes a public policy judgment that ending a pregnancy warrants less financial pause than treating a chronic illness or scheduling an elective surgery. For those who hold that human life begins at fertilization and carries inherent dignity, this design choice is not incidental; it is the operative point of the legislation.
The malpractice insurer provision compounds the concern. Actuarial risk assessment is the foundational mechanism by which malpractice insurers allocate accountability across the medical community. Barring adverse action "solely" on the basis of performing legally protected reproductive health services removes a market-accountability tool for this category of practice that remains fully available to every other medical specialty. The effect is a form of regulatory insulation that the bill's drafters have chosen to extend specifically to abortion providers and that no other specialty enjoys by statute.
The American Council opposes A4349. The bill does not merely expand access to a contested procedure; it compels institutional participation across virtually every insurance arrangement in the state, eliminates cost-sharing as a deliberate structural feature, directs Medicaid funds toward abortion coverage, and grants abortion providers a statutory shield from normal malpractice-insurance market accountability. People of faith who believe every unborn child possesses inherent worth cannot in good conscience support legislation whose operative provisions are designed to dismantle the remaining structural considerations that distinguish abortion from routine medical care.
A4349 was introduced on February 19, 2026, and referred to the Assembly Financial Institutions and Insurance Committee, where it currently sits without a scheduled hearing. The bill carries a single prime sponsor, Assemblywoman Shanique Speight of District 29, which suggests it has not yet assembled the broader co-sponsorship coalition typically associated with leadership-backed priorities, though New Jersey's Democratic legislative majority means the bill faces a more favorable floor environment than it would in many other states. The 222nd Legislature's session calendar creates incremental pressure as the year advances, and committee action is the threshold step before any floor consideration is possible. Constituent contact directed at committee members is most consequential right now, before a hearing is scheduled and the bill's momentum, or lack of it, becomes clearer.